Pharmacovigilance QMS & Inspection Preparation Course (London, United Kingdom - November 22-23, 2018 ...

By On September 24, 2018

Pharmacovigilance QMS & Inspection Preparation Course (London, United Kingdom - November 22-23, 2018 ...

DUBLIN--(BUSINESS WIRE)--The "Pharmacovigilance QMS & Inspection Preparation" conference has been added to's offering.

Since the introduction of the new pharmacovigilance legislation in the EU, Quality Management Systems (QMS) and self-audits have become a hot and growing topic.

Companies have been increasingly challenged by regulators to implement risk-based audits where continual improvement of processes, systems and compliance to regulations needs to be demonstrated.

This is required from the top of the company organisation in all areas of regulatory activity from clinical, regulatory; pharmacoviglance, sales & marketing, IT and medical services.

This course is designed to help in both the assessments of risk and the whole CAPA and preventative action elements.

Who Should Attend:

  • QA representatives
  • Pharmacovigilance workers
  • Regulatory
  • Clinical administrators
  • Those responsible for the management of the CAPA systems.


Day One

The audit basics

  • The purpose of an audit
  • Qualifications of the auditor
  • The audit SOP & design
  • The difference between audits and inspections
  • Audit planning and risk assessments

The legislation and audits

  • The requirements to perform company audits
  • In-house versus external audits
  • What needs to be audited
  • Which departments need auditing for safety

Quality Management Systems (QMS)

  • Quality Management Systems - design
  • Quality cycles - expectations and deviations
  • Quality risk assessments
  • Key Performance Indicators (KPIs)
  • Quality failings and corrections

QMS and the audit report

  • The audit scope an d conduct
  • The audit report content
  • The grading of audit reports
  • Corrective action plans (root cause analysis)
  • Re-audits

Workshop session

Day Two

Introduction to PV inspections

  • Background
  • Purpose - design
  • Roles and responsibilities of the licence holder
  • Conduct of regulatory inspections

Risk-based inspections

  • Defining risk
  • Routine and for cause inspections
  • Triggers for an inspection
  • Who should attend the inspection

The pharmacovigilance inspection cycle

  • Pre-inspection questionnaires
  • Site visits & telephone audits
  • Results and CAPAs
  • Inspection follow up questionnaires
  • Follow up Inspections

Workshop session

Common findings from regulatory inspections

  • Grades of findings (how to grade findings)
  • How to grade findings in the same PV area
  • Allied findings in other Departments
  • KPIs versus legislation
  • Variations in major authority inspections

Final discussion session

For more information about this conference visit https://www.res

Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery

Source: Google News United Kingdom | Netizen 24 United Kingdom

« Prev Post
Next Post »